EVP, Investments & GC of Repros Therapeutics Inc (30-Year Financial, Insider Trades) George W. Lloyd (insider trades) bought 14,200 shares of RPRX on 06/18/2020 at an average price of $28 a share. The total cost of this purchase was $397,600.
Repros Therapeutics Inc is a development stage biopharmaceutical company. The Company is engaged in the development of new drugs to treat hormonal and reproductive system disorders. Repros Therapeutics Inc has a market cap of $2.03 billion; its shares were traded at around $51.29 .
CEO Recent Trades:
- CEO, Chairman of the Board, 10% Owner Pablo G. Legorreta bought 20,000 shares of RPRX stock on 06/18/2020 at the average price of $28. The price of the stock has increased by 83.18% since.
Directors and Officers Recent Trades:
- 10% Owner Capital Partners Gp, L.l Adage bought 3,000,000 shares of RPRX stock on 06/18/2020 at the average price of $28. The price of the stock has increased by 83.18% since.
- Director William E Ford bought 1,500,000 shares of RPRX stock on 06/18/2020 at the average price of $28. The price of the stock has increased by 83.18% since.
- EVP, Investments & GC George W. Lloyd bought 14,200 shares of RPRX stock on 06/18/2020 at the average price of $28. The price of the stock has increased by 83.18% since.
- Director, 10% Owner Mario Germano Giuliani bought 50,000 shares of RPRX stock on 06/18/2020 at the average price of $28. The price of the stock has increased by 83.18% since.
For the complete insider trading history of RPRX, click here
.
